Current status:
Cancelled Post Market
Current status date:
1999-09-17
DIN:
00086878
Electronic product monograph is not available
Route(s) of administration:
Oral
Number of active ingredient(s):
9
Schedule(s):
Schedule G (CDSA IV)
Anatomical Therapeutic Chemical (ATC):
See footnote 4
A14AA53 METANDIENONE, COMBINATIONS *
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
ASCORBIC ACID
|
150 MG
|
L-LYSINE HYDROCHLORIDE
|
100 MG
|
LIVER EXTRACT
|
50 MG
|
METHANDROSTENOLONE
|
2 MG
|
NICOTINAMIDE
|
20 MG
|
PYRIDOXINE HYDROCHLORIDE
|
.5 MG
|
THIAMINE MONONITRATE
|
7.5 MG
|
TRYPTOPHAN
|
10 MG
|
VITAMIN B2
|
7.5 MG
|